RECORD OF PROCEEDINGS
PHYSICAL DISABILITY BOARD OF REVIEW
NAME: XXXXXXXXXXXXXXX BRANCH OF SERVICE: ARMY
CASE NUMBER: PD1201453 DATE OF PLACEMENT ON TDRL: 20020129
BOARD DATE: 20130307 DATE OF PERMANENT SEPARATION: 20040704
SUMMARY OF CASE: Data extracted from the available evidence of record reflects that this
covered individual (CI) was an active duty SPC/E-4 (91B/Medic) medically separated for asthma.
She was treated, but did not improve adequately to fully perform her military duties, or meet
physical fitness standards. She was issued a permanent P3 profile and underwent a Medical
Evaluation Board (MEB). The MEB found her asthma condition medically unacceptable IAW AR
40-501, and referred her to a Physical Evaluation Board (PEB). Two orthopedic lower extremity
conditions (fractured right 4th metatarsal, and bilateral retropatellar pain syndrome) were also
listed on the DA Form 3947. The PEB found the asthma condition unfitting, but not sufficiently
stable for final, permanent adjudication. The CI was placed on the Temporary Disability Retired
List (TDRL) with 30% disability. The other two MEB conditions were both found not unfitting,
not rated. In October 2003, a second Army PEB was convened. The CI was found unfit due to
asthma, and separation was recommended at 10% based on intermittent inhalational
bronchodilator therapy, IAW the Veterans Administration Schedule for Rating Disabilities
(VASRD). The CI accepted the PEB findings and was medically separated with 10% disability.
CI CONTENTION: I feel I should have been rated higher than 10% because the side effects
from the meds made me gain weight and contributed to other conditions. I was still able to do
my job, but could not run anymore. My transition to civilian living was a hard process with 4
children. I still suffer with asthma and taking meds every day.
SCOPE OF REVIEW: The Boards scope of review as defined in DoDI 6040.44, is limited to those
conditions which were determined by the PEB to be specifically unfitting for continued military
service; or, when requested by the CI, those condition(s) identified but not determined to be
unfitting by the PEB. The unfitting asthma condition and the two orthopedic lower extremity
conditions (fractured right 4th metatarsal & bilateral retropatellar pain syndrome) meet the
criteria prescribed in DoDI 6040.44, and are accordingly addressed below. No other conditions
are within the Boards purview. Any condition outside the Boards defined scope of review may
be eligible for future consideration by the Army Board for Correction of Military Records.
RATING COMPARISON:
Final Army PEB dated 20031014
VA All Effective 20020130
Condition
Code
Rating
Condition
Code
Rating
Exam
TDRL
Sep.
Asthma
6602
30%
10%
Asthma
6602
30%
20020522
Fracture, Right Foot
Not Unfitting
Fracture, Right Foot
NSC
20020522
Bilateral Knee Pain
Not Unfitting
Arthritis, Bilateral Knees
5010
10%*
20020522
Major Depressive Disorder
9434
30%*
20020528
Gastroesophageal Reflux
7399-7346
10%
20020522
.No Additional MEB/PEB Entries.
Other Not Service Connected (NSC) x 2
20020522
Combined: 10%
Combined: 60%*
* Some of the VA ratings (Arthritis, Depression) were later increased by subsequent VA Rating Decisions
ANALYSIS SUMMARY: The Board acknowledges the sentiment expressed by the CI regarding
the impairment with which her conditions continue to burden her, and the significant impact
they have had on her quality of life. It is noted for the record that the Board is subject to the
same laws for disability entitlements as those under which the Disability Evaluation System
(DES) operates. The DES has neither the role nor the authority to compensate the CI for future
severity or potential complications of conditions. That role and authority is granted to the
Department of Veterans Affairs (DVA). The Board evaluates DVA evidence in arriving at its
recommendations, but its authority resides in evaluating the fairness of DES fitness and rating
determinations at the time of separation. Compensation can only be granted for the degree of
severity present at separation. The DVA, however, is empowered to re-evaluate a CIs
conditions for the purpose of adjusting the disability rating should the degree of impairment
change over time.
Asthma. The CI developed shortness of breath (SOB), and inability to run or perform physical
training. She was seen by pulmonary medicine and was diagnosed with mild persistent reactive
airway disease (RAD). She was treated with medications, and had some improvement in her
asthma. However, in spite of treatment, she was unable to fully perform her military
requirements and an MEB was initiated. The MEB clinical evaluation was in September 2001.
At that time, she was on four chronic daily medications (Flovent, Seroquel, Albuterol, and
Singulair). On exam, her lungs were clear to auscultation. As noted above, the CI was found
unfit for military service and was placed on the TDRL with a disability rating of 30%. The Board
considered all the evidence, and determined that a 30% rating at that time was appropriate
since she was being treated with inhalational anti-inflammatory medication and daily
inhalational bronchodilator therapy. The VASRD §4.97 criteria for a higher rating of 60% were
not met. Based on the evidence in the treatment record, the Board has no basis to recommend
a rating higher than 30%, at the time of initial placement on TDRL.
In August 2003, the CI had a clinical re-evaluation. She was going to college and majoring in
social work. She was physically active, playing softball 3 days a week and walking 2-3 miles per
day. She was on daily doses of Advair (twice a day) and Singulair (nightly), and using Albuterol
on an as needed basis. There had been no hospitalizations or emergency room visits for
asthma. Her lungs were clear to auscultation with no wheezes, rales, or rhonchi. There was
good air exchange to the bases of lungs.
The Board carefully reviewed all evidentiary information available and directs attention to its
rating recommendation based on the above evidence. The October 2003 Army PEB rated the
CIs asthma at 10% for requiring intermittent inhalational bronchodilator therapy. The PEB
concluded that the medication profile did not reflect daily controller therapy. For the readers
convenience, the VASRD §4.97 language for the 10% and 30% ratings (diagnostic code 6602) is
excerpted below:
FEV-1 of 56 to 70-percent predicted, or; FEV-1/FVC of 56 to 70
percent, or; daily inhalational or oral bronchodilator therapy,
or; inhalational anti-inflammatory medication .....................................................30
FEV-1 of 71 to 80-percent predicted, or; FEV-1/FVC of 71 to 80
percent, or; intermittent inhalational or oral bronchodilator therapy .................10
Using data from the treatment record, the Board determined that at the time of final
separation from military service, the CI was being treated with daily inhalational Advair. This
would justify a 30% rating. Advair is a dual agent consisting of Fluticasone (a corticosteroid
anti-inflammatory), and Salmeterol (a long-acting beta adrenergic bronchodilator).
There was no evidence for respiratory failure, frequent exacerbations requiring physician
intervention, or use of systemic corticosteroids. Therefore, a higher rating of 60% was not
justified. After due deliberation, considering all of the evidence and mindful of VASRD §4.3
(reasonable doubt), the Board recommends by majority decision (2:1 vote) a permanent
disability rating of 30% for the asthma condition.
Other PEB Conditions. Two lower extremity orthopedic conditions (fractured right 4th
metatarsal, and bilateral retropatellar pain syndrome) were adjudicated by the PEB as not
unfitting. The Boards first charge with respect to these conditions is an assessment of the
appropriateness of the PEBs fitness adjudication. The Boards threshold for countering fitness
determinations is higher than the VASRD §4.3 (reasonable doubt) standard used for its rating
recommendations, but remains adherent to the DoDI 6040.44 fair and equitable standard.
Both of these conditions were reviewed by the action officer and considered by the Board.
There was no indication from the record that either of these conditions significantly interfered
with satisfactory duty performance. After due deliberation in consideration of the
preponderance of the evidence, the Board concluded that there was insufficient cause to
recommend a change in the PEB fitness determination for these two conditions, and therefore,
no additional disability ratings can be recommended.
BOARD FINDINGS: IAW DoDI 6040.44, provisions of DoD or Military Department regulations or
guidelines relied upon by the PEB will not be considered by the Board to the extent they were
inconsistent with the VASRD in effect at the time of the adjudication. The Board did not
surmise from the record or PEB ruling in this case that any prerogatives outside the VASRD
were exercised. In the matter of the asthma condition, the Board recommends by majority
decision (2:1 vote) a permanent disability rating of 30%, coded 6602 IAW VASRD §4.97. The
single voter for dissent (who recommended a 10% permanent rating) did not elect to write a
minority opinion. In the matter of the fractured 4th metatarsal and the bilateral retropatellar
pain syndrome, the Board unanimously recommends no change from the PEB determination as
not unfitting. There were no other conditions within the Boards scope of review for
consideration.
RECOMMENDATION: The Board recommends that the CIs prior determination be modified as
follows; and, that the discharge with severance pay be recharacterized to reflect permanent
disability retirement, effective as of the date of her prior medical separation.
UNFITTING CONDITION
VASRD CODE
RATING
PERMANENT
Asthma
6602
30%
COMBINED
30%
The following documentary evidence was considered:
Exhibit A. DD Form 294, dated 20120805, w/atchs
Exhibit B. Service Treatment Record
Exhibit C. Department of Veterans Affairs Treatment Record
XXXXXXXXXXXXXXXXXXXXXX, DAF
Acting Director
Physical Disability Board of Review
SFMR-RB
MEMORANDUM FOR Commander, US Army Physical Disability Agency
(TAPD-ZB / XXXXXXXXXXX), 2900 Crystal Drive, Suite 300, Arlington, VA 22202-3557
SUBJECT: Department of Defense Physical Disability Board of Review Recommendation
for XXXXXXXXXXXXXXXXXX, AR20130005348 (PD201201453)
1. Under the authority of Title 10, United States Code, section 1554(a), I approve the
enclosed recommendation of the Department of Defense Physical Disability Board of
Review (DoD PDBR) pertaining to the individual named in the subject line above to
recharacterize the individuals separation as a permanent disability retirement with the
combined disability rating of 30% effective the date of the individuals original medical
separation for disability with severance pay.
2. I direct that all the Department of the Army records of the individual concerned be
corrected accordingly no later than 120 days from the date of this memorandum:
a. Providing a correction to the individuals separation document showing that
the individual was separated by reason of permanent disability retirement effective the
date of the original medical separation for disability with severance pay.
b. Providing orders showing that the individual was retired with permanent
disability effective the date of the original medical separation for disability with
severance pay.
c. Adjusting pay and allowances accordingly. Pay and allowance adjustment will
account for recoupment of severance pay, and payment of permanent retired pay at
30% effective the date of the original medical separation for disability with severance
pay.
d. Affording the individual the opportunity to elect Survivor Benefit Plan (SBP)
and medical TRICARE retiree options.
3. I request that a copy of the corrections and any related correspondence be provided
to the individual concerned, counsel (if any), any Members of Congress who have
shown interest, and to the Army Review Boards Agency with a copy of this
memorandum without enclosures.
BY ORDER OF THE SECRETARY OF THE ARMY:
Encl XXXXXXXXXXXXXXXXX
Deputy Assistant Secretary
(Army Review Boards)
AF | PDBR | CY2009 | PD2009-00427
The CI was therefore medically separated with a 10% disability rating. Asthma Condition . Given the consistent record of the CI’s being prescribed and using daily medication, the CI meets the 30% criteria of “daily inhalational or oral bronchodilator therapy, or; inhalational anti-inflammatory medication.” All evidence considered, the Board recommends coding 6602 at 30% as the fair, permanent separation rating for Asthma in this case.
AF | PDBR | CY2014 | PD-2014-03148
Both the Air Force PEB and the VA coded the pulmonary condition 6602 (Asthma). The PEB rated it 10%, and the VA rated it 30%. Eight months later, she was using the anti-inflammatory corticosteroid Motametasone.Following a thorough review of the evidence in the treatment record, the Board concluded that it was more likely than not that the CI was using inhalational anti-inflammatory medication at the time of separation from service.
AF | PDBR | CY2013 | PD 2013 00179
It is limited to those conditions determined by the PEB to be unfitting for continued military service and those conditions identified but not determined to be unfitting by the PEB when specifically requested by the CI. The Board directs attention to its rating recommendationbased on the above evidence.Both the FPEB and the VA rated asthma condition,under code 6620, asthma, bronchial, IAW §4.97 but at different rating levels; the FPEB rated 10%citing intermittent use of medication; and the...
AF | PDBR | CY2013 | PD-2013-02334
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of theVASRD standards to the unfitting medical condition at the time of separation. The §4.97 criteria for a 30% rating are “FEV-1 of 56- to 70-percent predicted, or; FEV-1/FVC of 56 to 70 percent, or; daily inhalational or oral bronchodilator therapy, or; inhalational anti-inflammatory medication;” and, those for 10% are “FEV-1 of 71- to 80-percent...
AF | PDBR | CY2013 | PD-2013-02236
In December 2004 theMEB found the asthma condition had stabilized sufficiently and the PEB adjudicated “exertion asthma” unfitting, rated at 10% disability and the CI was removed from the TDRL on 30 December 2004. The Board deliberated if the TDRL NARSUM current medications’listing oral Singulair was supported by the record and if it met the VASRD 6602 30% rating criteria for daily oral bronchodilator therapy.The Board discussed the evidence of record concerning Singulair use.Singulair was...
AF | PDBR | CY2013 | PD-2013-02522
The rating for the unfitting asthma condition is addressed below. Post-Separation)ConditionCodeRatingConditionCodeRatingExam Bronchial Asthma6699-660210%Asthma6602100%20070531Other x 1 (Not in Scope)Other x 5 Combined: 10%Combined: 100% *Derived from VA Rating Decision (VARD) dated 20060801 (most proximate to date of separation (DOS)) ANALYSIS SUMMARY :The Board also acknowledges the CI’s contention that suggests a higher service rating should have been granted on the unfitting medical...
AF | PDBR | CY2014 | PD-2014-02094
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of theVASRD standards to the unfitting medical condition at the time of separation. A VA Compensation and Pension (C&P) examination was conducted on 8 February 2006 (a monthafter separation), and documented only the symptom of “shortness of breath with forward bending or lifting;” and, and stated “she does not have any asthma attacks ... [and] ... no...
AF | PDBR | CY2011 | PD2011-00146
As noted above, the Army PEB found him unfit, and he was medically separated with a 10% disability rating. His lung exam was normal, with no wheezes noted. The Board does not have the authority to render fitness or rating recommendations for any conditions not considered by the DES.
AF | PDBR | CY2012 | PD2012 01655
The CI was then medically separated. In reference to medications, the examiner simply stated “Now for asthma, she uses inhalers.” The VA PFT evidence cited an FEV1 of 103% predicted, and did not document an FVC. I have carefully reviewed the evidence of record and the recommendation of the Board.
AF | PDBR | CY2009 | PD2009-00263
The PEB’s DA Form 199 dated 20050413 indicated “Asthma, with normal spirometry, on intermittent inhalational bronchodilator therapy.” The PEB specified “Medication profile shows no controller medication between March – April 2004 and 15 February 2005.” The PEB permanent separation rating was 6602 at 10%; and the VASRD 10% criteria contains the phrasing “intermittent inhalational or oral bronchodilator therapy.” There is therefore no evidence that the provisions of DoDI 1332.39 were applied. ...